How AI can help to tackle COVID-19

Loubna Bouarfa

CEO, Okra Technologies, Cambridge, UK

Michel Bouvier

CEO, Institute for Research in Immunology and Cancer, Université de Montréal, Canada

Giovanni Briganti

Senior fellow, I3h Institute, Université libre de Bruxelles, Belgium

Michel Goldman

Founder of the I3h Institute

Philippe Moingeon

Head of Immuno-inflammation, Servier Pharmaceuticals, Neuilly-sur-Seine, France